Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism

Withdrawn before enrolling · Not applicable

Conditions studied: Alcohol Drinking, Depression, Smoking Cessation, Attention Deficit Disorder

In brief

The two purposes of this study are 1. to determine what effect the chronic and moderate/heavy drinking of alcoholic beverages has 1. on the blood level of bupropion and chlorzoxazone and their major breakdown products in the blood and 2. on the stimulant effect of bupropion and 2. to determine what effect a normal and common (25% frequency) genetic variation of a specific liver enzyme (that breaks down bupropion) has 1. on the blood levels of bupropion and its major breakdown products in the blood and 2. on the stimulant effect of bupropion. Two groups of volunteers will be recruited for this study: 1. volunteers who drink moderate to heavy amounts of alcohol frequently and 2. volunteers who usually do not drink alcohol. Volunteers will NOT be asked to change their drinking (or nondrinking) habits during the study.

Key facts

Study ID

NCT00330434

Run by

Tufts University

People needed

0

Starts

2005-12-01

Expected to finish

2008-04-01

Last updated by the study team

2020-11-10

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults who are 21 - 55 years of age.
• Either 1) Moderate-to-heavy drinkers who drink on average more than 14 but less than 28 drinks per week; OR 2) adults who normally abstain from drinking alcohol.

You may not qualify if…

• Participants who are currently taking prescription medications (including oral contraceptives)
• Pregnancy
• Body mass index (BMI) greater than 30
• History of seizures or eating disorders

Where it is running

• Tufts University School of Medicine — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.